default author photo

Hiroshige Yoshioka

Kansai Medical University

Hirakata City

Japan

  • Kansai Medical University

SCHOLARLY PAPERS

3

DOWNLOADS

112

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial

Number of pages: 42 Posted: 05 Dec 2025
Shota Omori, Hirotsugu Kenmotsu, Shogo Nomura, Hideyuki Harada, Satoshi Ishikura, Masahiro Konno, Masahiko Ando, Hiroki Izumi, Yuki Shinno, Masahide Oki, Takeshi Masuda, Toshihide Yokoyama, Yukio Hosomi, Yukiko Nakamura, Shuji Murakami, Takashi Kurosaki, Hiroshige Yoshioka, Koichi Azuma, Kazuya Tsubouchi, Hiroshi Nokihara, Satoru Miura, Haruko Daga, Hironori Yoshida, Satoshi Hirano, Noriko Mitome, Haruhiko Fukuda, Isamu Okamoto and Toshiaki Takahashi
affiliation not provided to SSRN, Shizuoka Cancer Center - Division of Thoracic Oncology, University of Tokyo - Department of Biostatistics and Bioinformatics, Shizuoka Cancer Center, affiliation not provided to SSRN, Shizuoka Cancer Center, Nagoya University, National Cancer Center Hospital East, National Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Hiroshima University - Hiroshima University Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Kanagawa Cancer Center, affiliation not provided to SSRN, Kansai Medical University, Kurume University - Department of Internal Medicine, Kyushu University, National Center for Global Health and Medicine, Niigata Cancer Center Hospital, Osaka City General Hospital, Kyoto University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, Kyushu University - Kyushu University Hospital and Shizuoka Cancer Center
Downloads 54 (1,031,043)

Abstract:

Loading...

locally advanced, Non-small cell lung cancer (NSCLC), older patients, chemoradiotherapy, daily low-dose carboplatin, carboplatin plus nab-paclitaxel

2.

Development of prediction model for zone-specific lymph node metastasis in clinical stage I–II non-small cell lung cancer: a supplementary analysis of Japan Clinical Oncology Group study 1413

Number of pages: 53 Posted: 03 Nov 2025
Mitsuhiro Isaka, Tomoyuki Hishida, Hisashi Saji, Masashi Wakabayashi, Yasuhisa Ohde, Yasuhiro Tsutani, Makoto Endo, Takahiro Mimae, Tomohiro Miyoshi, Tetsuya Isaka, Aritoshi Hattori, Hiroshige Yoshioka, Ryu Nakajima, Masaya Yotsukura, Tomohiro Maniwa, Kazuo Nakagawa, Noriko Mitome, Yuta Sekino, Haruhiko Fukuda, Keiju Aokage, Shun-ichi Watanabe and Morihito Okada
Shizuoka Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, National Cancer Center Hospital, Shizuoka Cancer Center, Hiroshima University, Yamagata Prefectural Central Hospital, Hiroshima University, affiliation not provided to SSRN, Kanagawa Cancer Center, Juntendo University, Kansai Medical University, Osaka City General Hospital - Department of Thoracic Surgery, National Cancer Center Hospital, Osaka International Cancer Institute, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, affiliation not provided to SSRN, National Cancer Center Hospital - Department of Thoracic Surgery and Hiroshima University - Department of Surgical oncology
Downloads 39 (1,196,171)

Abstract:

Loading...

non-small cell lung cancer, clinical stage I-II, Lymph node metastasis, prediction model, lymph node dissection, Nomogram

3.

Adjuvant Chemotherapy Intensity and Prognosis in Completely Resected High-Grade Neuroendocrine Lung Carcinoma: A Post Hoc Analysis of JCOG1205/1206

Number of pages: 43 Posted: 22 Apr 2026
Tetsuya Isaka, Hirotsugu Kenmotsu, Masashi Wakabayashi, Hiroshige Yoshioka, Yoshihisa Shimada, Yasuhiro Tsutani, Kazuo Nakagawa, Masaya Yotsukura, Noriko Mitome, Takeshi Uozumi, Haruko Daga, Hiroshi Tanaka, Takashi Kasai, Seiji Niho, Masahiro Tsuboi, Haruhiko Fukuda, Keiju Aokage, Isamu Okamoto and Shun-ichi Watanabe
Kanagawa Cancer Center, Shizuoka Cancer Center - Division of Thoracic Oncology, National Cancer Center Hospital, Kansai Medical University, University of Tokyo - Department of Surgery, Hiroshima University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, Osaka City General Hospital, Niigata Cancer Center Hospital, affiliation not provided to SSRN, Dokkyo Medical University, National Cancer Center Hospital East - Department of Thoracic Surgery, National Cancer Center Hospital, affiliation not provided to SSRN, Kyushu University - Kyushu University Hospital and National Cancer Center Hospital - Department of Thoracic Surgery
Downloads 19 (1,470,786)

Abstract:

Loading...

high-grade neuroendocrine carcinoma, Small-cell lung cancer, large-cell neuroendocrine carcinoma, cisplatin, irinotecan, etoposide, Relative dose intensity